Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2023-02-01
2023-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Xylitol on Oral Microbiota in Children
NCT01528969
Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.
NCT06966492
Analysis of Stannous Fluoride in GCF and Subgingival Plaque
NCT03296657
Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes
NCT05778383
Evaluation of the Antibacterial Effect of a Toothpaste Containing Zinc Lactate
NCT05628571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2.2. Fortification of Zn and Se in the rice flour cookies Cookies were made with rice flour samples supplemented with Zn and Se extracted from shiitake mushroom, at concentrations of 100, 150, and 200 mg/kg of cookie dough, according to the usual process outlined by AACC. Butter, sugar, salt, baking powder, egg, ghee and water were used as common ingredients in all treatments, while Zn, and Se extracted from shiitake powder were used as variable ingredients according to the treatments plan given in ST 1. All ingredients were weighed precisely and mixed homogeneously in laboratory mixer bowl for 10 minutes for each treatment group (T0, T1, T2 and T3). After the homogenous mixing, a resting period of 10 to 15 minutes was applied. The dough was converted into a 5mm thick sheet which was cut into cookies using suitable molds. Baking was accomplished at 170°C for 12 to 15 minutes followed by cooling at room temperature. After cooling, cookies were packed in propylene bags. However, each serving (one cookie) in groups T1, T2, and T3 provided an average of 10 mg:10 µg, 15 mg:15 µg, and 20 mg:20 µg of Zn and Se, respectively, as verified by formulation and batch testing. All batches were processed under standardized conditions to ensure ingredient homogeneity and batch to batch uniformity.
Anthropometric measurements, Microbiological and Hematological Parameters were measured 2.4. Statistical Analysis All resulting data were analyzed statistically to test the significance level (p≤0.05) via the completely randomized design (CRD) by using analytical software statistix (version 8.1).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Patients took Myrin P Fort
Myrin P Fort
Patient took Myrin P Fort
Zn + Se supplemented cookies
patients took Zn + Se supplemented cookies
Zn + Se + Myrin P Fort
patients took Zn + Se
\+ Myrin P Fort
Zn + Se + Myrin P Fort
Patients took Zn + Se
\+ Myrin P Fort
Zn + Se supplemented cookies
patients took Zn + Se supplemented cookies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myrin P Fort
Patient took Myrin P Fort
Zn + Se supplemented cookies
patients took Zn + Se supplemented cookies
Zn + Se + Myrin P Fort
patients took Zn + Se
\+ Myrin P Fort
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed diagnosis of pulmonary tuberculosis (Pul-TB) with positive acid-fast bacilli (AFB) in sputum samples.
Exclusion Criteria
* Patients who had been on anti-TB therapy for more than 2 months prior to enrollment.
30 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sana Noreen
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sana Noreen
Lahore, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-UOL-FAHS/906/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.